The Department of Health (DOH) reiterated that the Food and Drug Administration (FDA) has not approved any mpox vaccine to ...
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer ... produced at scale on a much shorter time scale than a new drug," said senior author Donald Ingber, M.D., Ph.D.
INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...
The U.S. Food and Drug Administration has cleared the AirPods Pro 2 to get the announced clinical-grade hearing aid features ...
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...
After pushing back the decision date for Applied Therapeutics’ metabolic disorder drug govorestat, the FDA has now decided ...
PH-284 is under clinical development by VistaGen Therapeutics and currently in Phase II for Cachexia. According to GlobalData, Phase II drugs for Cachexia does not have sufficient historical data to ...
The country has logged 18 confirmed cases of mpox (formerly monkeypox) as of Aug. 18, Health Secretary Teodoro Herbosa said ...